Development of a guideline for orthopaedic management in the care of children and young people with Duchenne muscular dystrophy in the UK National Health Service
- PMID: 40575436
- PMCID: PMC12187703
- DOI: 10.1177/18632521251348972
Development of a guideline for orthopaedic management in the care of children and young people with Duchenne muscular dystrophy in the UK National Health Service
Abstract
People living with the rare, genetic condition Duchenne muscular dystrophy have particular orthopaedic care needs that are not universally understood or implemented at sites across the UK, putting them at risk of not receiving the correct treatment. They may require orthopaedic management and intervention for contractures caused by their muscle weakness. Importantly, they are also at a high risk of fractures due to increased bone fragility as part of the nature of Duchenne muscular dystrophy but also resulting from reduced weight-bearing and from the long-term use of corticosteroids as standard of care. In addition, progressive skeletal muscle weakness increases the risk of falls that may cause fractures. DMD Care UK's orthopaedic working group has developed a guideline by consensus to inform all those involved in the orthopaedic management of people with Duchenne muscular dystrophy about the care needs and imperatives. This covers children and adults and focuses on fracture management and elective orthopaedic procedures. The guideline has been endorsed by the British Society for Children's Orthopaedic Surgery.
Keywords: Duchenne muscular dystrophy; elective surgery; fracture management; guidelines.
© The Author(s) 2025.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
Figures
Similar articles
-
Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline.Cochrane Database Syst Rev. 2021 Dec 1;12(12):CD013720. doi: 10.1002/14651858.CD013720.pub3. Cochrane Database Syst Rev. 2021. PMID: 34850383 Free PMC article.
-
Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline.Cochrane Database Syst Rev. 2021 Nov 8;11(11):CD013720. doi: 10.1002/14651858.CD013720.pub2. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2021 Dec 1;12:CD013720. doi: 10.1002/14651858.CD013720.pub3. PMID: 34748221 Free PMC article. Updated.
-
Corticosteroids for the treatment of Duchenne muscular dystrophy.Cochrane Database Syst Rev. 2016 May 5;2016(5):CD003725. doi: 10.1002/14651858.CD003725.pub4. Cochrane Database Syst Rev. 2016. PMID: 27149418 Free PMC article.
-
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3. Syst Rev. 2024. PMID: 39593159 Free PMC article.
-
Sexual Harassment and Prevention Training.2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 36508513 Free Books & Documents.
References
-
- Flanigan KM. Duchenne and Becker muscular dystrophies. Neurol Clin 2014; 32(3): 671–688. - PubMed
LinkOut - more resources
Full Text Sources